Psychopharmacology Tips


Binge Eating Disorder: Should You Use Vyvanse?

Binge Eating Disorder: Should You Use Vyvanse?

In January of this year, the FDA approved the stimulant lisdexamfetamine (Vyvanse) as the first drug with an indication for binge eating disorder (BED). Patients are hearing the buzz and may be asking you to prescribe it, but you may have some questions first.

Medications for Childhood PTSD: It’s All Off-Label

Medications for Childhood PTSD: It’s All Off-Label

In 2011, we wrote a review of medications for PTSD in children and found, unfortunately, that data to inform true evidence-based practice was scant. There are still no psychotropic medications that have been proven effective in randomized controlled trials for children with PTSD and there are no FDA approved medications for this population.

The Facts on Tardive Dyskinesia

Issues in Psychopharmacology - The Carlat Psychiatry Report (TCPR)

We’re all aware that neuroleptics and other dopamine-receptor blocking agents (DRBAs) can cause a variety of movement disorders, often referred to as extrapyramidal syndromes (EPS).

Research Update

The New Three-Month Version of Injectable Paliperidone: Should You Use It?

Patients with schizophrenia often stop taking their medications, so long-acting injectable antipsychotics (LAIs) are potentially good ways to make sure these patients have some medication in their systems over the long term.

Free Article

Drug Interactions in Psychiatry: A Practical Review [Free Article]

In this article we’ll survey those drug interactions that are most likely to become troublesome in day to day psychiatric practice.